These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34920960)

  • 1. Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study.
    Legrand L; Weinsaft JW; Pousset F; Ewenczyk C; Charles P; Hatem S; Heinzmann A; Biet M; Durr A; Redheuil A
    Arch Cardiovasc Dis; 2022 Jan; 115(1):17-28. PubMed ID: 34920960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.
    Bit-Avragim N; Perrot A; Schöls L; Hardt C; Kreuz FR; Zühlke C; Bubel S; Laccone F; Vogel HP; Dietz R; Osterziel KJ
    J Mol Med (Berl); 2001; 78(11):626-32. PubMed ID: 11269509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked variation in the cardiomyopathy associated with Friedreich's ataxia.
    Dutka DP; Donnelly JE; Nihoyannopoulos P; Oakley CM; Nunez DJ
    Heart; 1999 Feb; 81(2):141-7. PubMed ID: 9922348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy.
    Gregory SA; MacRae CA; Aziz K; Sims KB; Schmahmann JD; Kardan A; Morss AM; Ellinor PT; Tawakol A; Fischman AJ; Gewirtz H
    Coron Artery Dis; 2007 Feb; 18(1):15-22. PubMed ID: 17172925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic and functional characteristics of the heart in Friedreich's ataxia.
    Unverferth DV; Schmidt WR; Baker PB; Wooley CF
    Am J Med; 1987 Jan; 82(1):5-10. PubMed ID: 3799693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac involvement in Friedreich's heredo-ataxia].
    Bertoni PD; Canziani R; Cozzi G; Arancio F; Marforio S
    G Ital Cardiol; 1986 Jan; 16(1):22-9. PubMed ID: 2940141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified mouse model of Friedreich's ataxia with conditional
    Perfitt TL; Huichalaf C; Gooch R; Kuperman A; Ahn Y; Chen X; Ullas S; Hirenallur-Shanthappa D; Zhan Y; Otis D; Whiteley LO; Bulawa C; Martelli A
    Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H357-H369. PubMed ID: 38038720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friedreich's ataxia. Revision of the phenotype according to molecular genetics.
    Schöls L; Amoiridis G; Przuntek H; Frank G; Epplen JT; Epplen C
    Brain; 1997 Dec; 120 ( Pt 12)():2131-40. PubMed ID: 9448568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI.
    Meyer C; Schmid G; Görlitz S; Ernst M; Wilkens C; Wilhelms I; Kraus PH; Bauer P; Tomiuk J; Przuntek H; Mügge A; Schöls L
    Mov Disord; 2007 Aug; 22(11):1615-22. PubMed ID: 17546670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
    Libri V; Yandim C; Athanasopoulos S; Loyse N; Natisvili T; Law PP; Chan PK; Mohammad T; Mauri M; Tam KT; Leiper J; Piper S; Ramesh A; Parkinson MH; Huson L; Giunti P; Festenstein R
    Lancet; 2014 Aug; 384(9942):504-13. PubMed ID: 24794816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiogram in Friedreich's ataxia: A short-term surrogate endpoint for treatment efficacy.
    Mastroianno S; Germano M; Maggio A; Massaro R; Potenza DR; Russo A; Carella M; Di Stolfo G
    Ann Noninvasive Electrocardiol; 2021 Jul; 26(4):e12813. PubMed ID: 33151022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Friedreich's ataxia: clinical aspects and pathogenesis.
    Pandolfo M
    Semin Neurol; 1999; 19(3):311-21. PubMed ID: 12194387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
    Hausse AO; Aggoun Y; Bonnet D; Sidi D; Munnich A; Rötig A; Rustin P
    Heart; 2002 Apr; 87(4):346-9. PubMed ID: 11907009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-onset Friedreich's ataxia revisited.
    Lecocq C; Charles P; Azulay JP; Meissner W; Rai M; N'Guyen K; Péréon Y; Fabre N; Robin E; Courtois S; Guyant-Maréchal L; Zagnoli F; Rudolf G; Renaud M; Sévin-Allouet M; Lesne F; Alaerts N; Goizet C; Calvas P; Eusebio A; Guissart C; Derkinderen P; Tison F; Brice A; Koenig M; Pandolfo M; Tranchant C; Dürr A; Anheim M
    Mov Disord; 2016 Jan; 31(1):62-9. PubMed ID: 26388117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyopathy of Friedreich ataxia.
    Weidemann F; Störk S; Liu D; Hu K; Herrmann S; Ertl G; Niemann M
    J Neurochem; 2013 Aug; 126 Suppl 1():88-93. PubMed ID: 23859344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia.
    Stefanescu MR; Dohnalek M; Maderwald S; Thürling M; Minnerop M; Beck A; Schlamann M; Diedrichsen J; Ladd ME; Timmann D
    Brain; 2015 May; 138(Pt 5):1182-97. PubMed ID: 25818870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
    Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
    Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: A phase II, open-label, prospective study.
    Qureshi MY; Patterson MC; Clark V; Johnson JN; Moutvic MA; Driscoll SW; Kemppainen JL; Huston J; Anderson JR; Badley AD; Tebben PJ; Wackel P; Oglesbee D; Glockner J; Schreiner G; Dugar S; Touchette JC; Gavrilova RH
    J Inherit Metab Dis; 2021 Mar; 44(2):502-514. PubMed ID: 32677106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic findings in Friedreich's ataxia.
    Cote M; Davignon A; Elias G; Solignac A; Geoffroy G; Lemieux B; Barbeau A
    Can J Neurol Sci; 1976 Nov; 3(4):333-6. PubMed ID: 1000418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.